Incorporating Digital Technology into Clinical Trials

Incorporating Digital Technology into Clinical TrialsOctober 2016

2

About Perficient

Perficient is the leading digital transformation consulting firm serving Global 2000 and

enterprise customers throughout North America.

With unparalleled information technology, management consulting, and creative capabilities, Perficient and its Perficient Digital agency deliver vision, execution, and value with outstanding digital experience, business optimization, and industry solutions.

3

Perficient ProfileFounded in 1997

Public, NASDAQ: PRFT

2015 revenue $473.6 million

Major market locations:Allentown, Atlanta, Ann Arbor, Boston, Charlotte, Chattanooga, Chicago, Cincinnati, Columbus, Dallas, Denver, Detroit, Fairfax, Houston, Indianapolis, Lafayette, Milwaukee, Minneapolis, New York City, Northern California, Oxford (UK), Southern California, St. Louis, Toronto

Global delivery centers in China and India

3,000+ colleagues

Dedicated solution practices

~95% repeat business rate

Alliance partnerships with major technology vendors

Multiple vendor/industry technology and growth awards

Param SinghDirector, Clinical Operations Solutions

5

• Life sciences is going digital

• Subject recruitment

• Subject screening

• Informed consent

• Clinical data collection

• Post-market / real-world data

• Q&A

• Next steps

Agenda

6

• Acute care Preventive care

• Specialists Self-care

• Hospitals Home care

• Single biometric indicators Multiple indicators

• Empirical evidence for “typical” patients

Personalized, precision medicine

• Specialized information silos

Centralized, accessible knowledge centers

Bottom Line: Life sciences needs to understand, harness, and capitalize on these shifts (i.e., we need to “go digital”)

Healthcare Shifts

7

“The mClinical team is redefining when, where and how patients engage in clinical research through innovative digital and mobile solutions to support communications and data collection for recruitment, screening, electronic consent, study participation retention and compliance, and patient reported outcomes.”

Seth Schulman, Head of Clinical Excellence and Innovation, Pfizer

8

Subject Recruitment

9

Subject Screening

10

Informed Consent

11

Clinical Data Collection

12

Post-Market / Real-World Data

QuestionsType your question into the chat box

14

• Mining Online Communities and Social Networks for Safety Signals | registerNovember 17, 2016 

• How to Review, Cleanse, and Transform Clinical Data in Oracle InForm | registerDecember 8, 2016

Follow Us Online• Perficient.com/SocialMedia• Facebook.com/Perficient• Twitter.com/Perficient_LS• Blogs.perficient.com/LifeSciences

Thank You